Computerized touch-panel screening tests for detecting mild cognitive impairment and alzheimer’s disease

Internal Medicine

Volumn 54, Issue 8, 2015, Pages 895-902

  Fukui, Yusuke ^a   Yamashita, Toru ^a   Hishikawa, Nozomi ^a   Kurata, Tomoko ^a   Sato, Kota ^a   Omote, Yoshio ^a   Kono, Syoichiro ^a   Yunoki, Taijun ^a   Kawahara, Yuko ^a   Hatanaka, Noriko ^a   Tokuchi, Ryo ^a   Deguchi, Kentaro ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Affective disorder; Alzheimer s disease; Cognitive disorder; Dementia; Mild cognitive impairment; Screening test

Indexed keywords

ABES BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA; ACTIVITY OF DAILY LIVING ASSESSMENT; ADULT; AGED; ALZHEIMER DISEASE; APATHY; APATHY SCALE; ARTICLE; ASSESSMENT OF HUMANS; BEHAVIOR ASSESSMENT; CLINICAL DEMENTIA RATING; COGNITION ASSESSMENT; COMPUTER AIDED DESIGN; COMPUTER ANALYSIS; COMPUTERIZED TOUCH PANEL GAME; COMPUTERIZED TOUCH PANEL SCREENING TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIPLE REGRESSION; NEUROIMAGING; RECEIVER OPERATING CHARACTERISTIC; DAILY LIFE ACTIVITY; JAPAN; MASS SCREENING; NEUROPSYCHOLOGICAL TEST; PROCEDURES; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; HUMANS; JAPAN; MALE; MASS SCREENING; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS;

EID: 84927617263     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.3931     Document Type: Article

References (28)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-308, 1999.
2. Grundman M, Petersen RC, Ferris SH, et al. Alzheimer’s Disease Cooperative S. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61: 59-66, 2004.
3. Tsuboi K, Harada T, Ishii T, Morishita H, Ohtani H, Ishizaki F. Evaluation of the usefulness of a simple touch-panel method for the screening of dementia. Hiroshima J Med Sci 58: 49-53, 2009.
4. Maki Y, Yoshida H, Yamaguchi H. Computerized visuo-spatial memory test as a supplementary screening test for dementia. Psychogeriatrics 10: 77-82, 2010.
5. Inoue M, Jimbo D, Taniguchi M, Urakami K. Touch Panel-type Dementia Assessment Scale: a new computer-based rating scale for Alzheimer’s disease. Psychogeriatrics 11: 28-33, 2011.
6. Deguchi K, Kono S, Deguchi S, et al. A novel useful tool of computerized touch panel-type screening test for evaluating cognitive function of chronic ischemic stroke patients. J Stroke Cerebrovasc Dis 22: e197-e206, 2013.
7. Deguchi K, Kurata T, Deguchi S, et al. The efficacy of a novel computerized touch panel-type screening test to evaluate the cognitive function of patients with Parkinson’s disease. Neurosci Bio-med Engineering 1: 60-64, 2013.
8. Morimoto N, Kurata T, Sato K, Ikeda Y, Sato S, Abe K. Frontal dysfunctions of ALS-PBP patients in relation to their bulbar symptoms and rCBF decline. J Neurol Sci 319: 96-101, 2012.
9. Mueller SG, Weiner MW, Thal LJ, et al. Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimer’s Dementia 1: 55-66, 2005.
10. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43: 2412-2414, 1993.
11. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198, 1975.
12. Imai Y, Hasegawa K. The Revised Hasegawa’s Dementia scale (HDS-R) evalution of its usefulness as a screening test for dementia. J Hong Kong Coll Psychiatr 5: 20-24, 1994.
13. Abe K, Yamashita T, Hishikawa N, et al. A new simple score (ABS) for assessing behavioral and psychological symptoms of dementia. J Neurol Sci, 2015 (Epub ahead of print).
14. Yesavage JA. Geriatric depression scale. Psychopharmacol Bull 24: 709-711, 1988.
15. McCrea D, Arnold E, Marchevsky D, Kaufman BM. The preva-lence of depression in geriatric medical outpatients. Age Ageing 23: 465-467, 1994.
16. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical cor-relates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4: 134-139, 1992.
17. Galasko D, Bennett D, Sano M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord 11 (Suppl 2): S33-S39, 1997.
18. O’Bryant SE, Humphreys JD, Smith GE, et al. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol 65: 963-967, 2008.
19. de Jager CA, Schrijnemaekers AC, Honey TE, Budge MM. Detec-tion of MCI in the clinic: evaluation of the sensitivity and speci-ficity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE. Age Ageing 38: 455-460, 2009.
20. Fujiwara Y, Suzuki H, Yasunaga M, et al. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int 10: 225-232, 2010.
21. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parame-ter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56: 1143-1153, 2001.
22. Schuff N, Woerner N, Boreta L, et al; Alzheimer’s Disease Neuroimaging Initiative. MRI of hippocampal volume loss in early Alzheimer’s disease in relation to ApoE genotype and biomarkers. Brain 132: 1067-1077, 2009.
23. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 55: 306-319, 2004.
24. Pike KE, Savage G, Villemagne VL, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease. Brain 130: 2837-2844, 2007.
25. Jack CR Jr, Lowe VJ, Weigand SD, et al. Alzheimer’s Disease Neuroimaging I. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease. Brain 132: 1355-1365, 2009.
26. Shoji M, Matsubara E, Murakami T, et al. Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group. Neurobiol Aging 23: 363-370, 2002.
27. Blennow K, Hampel H. CSF markers for incipient Alzheimer’s disease. Lancet Neurol 2: 605-613, 2003.
28. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6: 734-746, 2007.